Profile
RBV Capital is a venture capital fund focused on life sciences, headquartered in an undisclosed location. Established in 2014, the firm specializes in investing in innovative biomedical projects. While the site provides little information on the team, RBV Capital is unique for its dedicated focus on the life sciences sector and its completed investment cycle indicating a shift towards divestment.
RBV Capital invests in the life sciences sector, specifically targeting innovative biomedical projects. The firm focuses on portfolio adjustments as it has completed its primary investment cycle. Information regarding specific check sizes and stages is not available, although their venture approach implies early to growth stages. No details are provided about their LPs or strategic partners.
The firm's portfolio includes a variety of innovative biomedical projects, though specific companies are not disclosed on their site. The emphasis on biomedical innovation suggests a proactive approach in contributing to health and science advancements.